80000 patients and families served by patient services
$22 million in research funds awarded to researchers
historic

KEY INITIATIVES

pm-july-2014-293x150

Enjoy the July Issue of
Our Monthly Newsletter

Read about the results of our efforts on Capitol Hill and much more.

iStock_000004063879Small2

Clinical Trial Enrollment

Let us help you by informing patients about your pancreatic cancer clinical trials. If you are conducting clinical trials, we want to know about your studies!

Volunteer Recruitment

Volunteer Recruitment

Our volunteers are second to none. Passionate, focused and relentless in their desire to change the course of history for pancreatic cancer. Are you ready to get involved?

Sign up for our Newsletter

LATEST NEWS
home-CR-report-90x70b

Now published in Cancer Research: a Pancreatic Cancer Action Network study predicting that pancreatic cancer will be the second leading cause of cancer-related death around 2020. Learn more.

flame

MM-398 combined with standard chemotherapy boosts overall survival by nearly 2 months in patients previously treated with gemcitabine. Learn more.

14 grants totaling nearly $5 million has been awarded to scientists and clinicians across the country.

Sixteen grants totaling more than $5.1 million have been awarded to scientists and clinicians across the country this year. Learn more.

© 2014 Pancreatic Cancer Action Network
PANCAN©, PURPLESTRIDE©, PURPLERIDE© PURPLEBOWL©, TEAMHOPE© and PANCREATIC CANCER ACTION NETWORK© are registered trademarks.

The Pancreatic Cancer Action Network is registered as a 501(c)(3) nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is # 33-0841281.

Terms of Use | Privacy Policy